Synthesis, characterizations and kinetic study of metal organic framework nanocomposite excipient used as extended release delivery vehicle for an antibiotic drug

Exploring Synthesis Strategies and Interactions between MOFs and Drugs for Controlled Drug Loading and Release, Characterizing Interactions Through Advanced Techniques

This study explores various aspects of Metal-Organic Frameworks (MOFs), focusing on synthesis techniques to adjust pore size and key ligands and metals for crafting carrier MOFs. It investigates MOF-drug interactions, including hydrogen bonding, van der Waals, and electrostatic interactions, along with kinetic studies. The multifaceted applications of MOFs in drug delivery systems are elucidated. The morphology and structure of MOFs are intricately linked to synthesis methodology, impacting attributes like crystallinity, porosity, and surface area. Hydrothermal synthesis yields MOFs with high crystallinity, suitable for catalytic applications, while solvothermal synthesis generates MOFs with increased porosity, ideal for gas and liquid adsorption. Understanding MOF-drug interactions is crucial for optimizing drug delivery, affecting charge capacity, stability, and therapeutic efficacy. Kinetic studies determine drug release rates and uniformity, vital for controlled drug delivery. Overall, comprehending drug-MOF interactions and kinetics is essential for developing effective and controllable drug delivery systems.

A magnetic stir bar sorbent of metal organic frameworks, carbon foam decorated zinc oxide and cryogel to enrich and extract parabens and bisphenols from food samples

A porous composite magnetic stir bar adsorbent was fabricated for the extraction and enrichment of parabens and bisphenols from selected beverage samples. The adsorbent comprised a metal organic framework, carbon foam decorated zinc oxide and magnetic nanoparticles embedded in polyvinyl alcohol cryogel. The porous composite stir bar adsorbent could adsorb parabens and bisphenols via hydrogen bonding, π-π and hydrophobic interactions. In the best conditions, linearity was good from 5.0 to 200.0 µg/L for methyl paraben, ethyl paraben and bisphenol A and from 10.0 to 200.0 µg/L for bisphenol B and butyl paraben. Limits of detection ranged from 1.5 to 3.0 µg/L. The developed composite stir bar was successfully applied to extract and determine parabens and bisphenols in fruit juice, beer and milk. Recoveries ranged from 89.5 to 99.5 % with RSDs lower than 6 %. The developed sorbent and new methodology were evaluated in terms of its green character with satisfactory results.

Lipid-Based Nanoparticles for Drug/Gene Delivery: An Overview of the Production Techniques and Difficulties Encountered in Their Industrial Development

Over the past decade, the therapeutic potential of nanomaterials as novel drug delivery systems complementing conventional pharmacology has been widely acknowledged. Among these nanomaterials, lipid-based nanoparticles (LNPs) have shown remarkable pharmacological performance and promising therapeutic outcomes, thus gaining substantial interest in preclinical and clinical research. In this review, we introduce the main types of LNPs used in drug formulations such as liposomes, nanoemulsions, solid lipid nanoparticles, nanostructured lipid carriers, and lipid polymer hybrid nanoparticles, focusing on their main physicochemical properties and therapeutic potential. We discuss computational studies and modeling techniques to enhance the understanding of how LNPs interact with therapeutic cargo and to predict the potential effectiveness of such interactions in therapeutic applications. We also analyze the benefits and drawbacks of various LNP production techniques such as nanoprecipitation, emulsification, evaporation, thin film hydration, microfluidic-based methods, and an impingement jet mixer. Additionally, we discuss the major challenges associated with industrial development, including stability and sterilization, storage, regulatory compliance, reproducibility, and quality control. Overcoming these challenges and facilitating regulatory compliance represent the key steps toward LNP's successful commercialization and translation into clinical settings.

Three-Dimensional Neodymium Metal-Organic Framework for Catalyzing the Cyanosilylation of Aldehyde and the Synthesis of 2,3-Dihydroquinazolin-4(1H)-one Derivatives

In this work, a novel 3D lanthanide metal-organic framework (Ln-MOF) Nd-cdip (H₄cdip = 5,5'-carbonyldiisophthalic acid) was successfully synthesized, which could be used as an efficient heterogeneous catalyst for cyanosilylation and the synthesis of 2,3-dihydroquinazolin-4(1H)-one derivatives at room temperature based on the Lewis acid sites in the channels of the MOF. Moreover, Nd-cdip had an excellent turnover number (500) for catalyzing cyanosilylation in no solvent condition. Nd-cdip could be reused in both of the above-mentioned reactions at least five times without a significant decrease in yield. The possible mechanism of cyanosilylation catalyzed by Nd-cdip was studied by using the luminescence properties of Tb-cdip, which has the same structure and functions as Nd-cdip. Furthermore, both reactions catalyzed by Nd-cdip were fitted to zero-order dynamics.

The Effectiveness of MOFs for the Removal of Pharmaceuticals from Aquatic Environments: A Review Focused on Antibiotics Removal

There is an increasing level of various pollutants and their persistence in aquatic environments. The improper use of antibiotics and their inefficient metabolism in organisms result in their release into aquatic environments. Antibiotic abuse has led to hazardous effects on human health. Thereby, efficient removal of pharmaceuticals, particularly antibiotics, from wastewater and contaminated water bodies is greatly interested in international research communities. Metal-organic framework (MOF) materials, as a hybrid group of material containing metallic center and organic linkers, offer a porous structure that is highly efficient for removing different pollutants from contaminated water and wastewater streams. This article aims to review the recent advancement in using MOF-based adsorbents and catalysts for the removal of pharmaceuticals, especially antibiotics, from polluted water. Applying MOFs-based structures for removing antibiotics using photocatalytic removal and adsorptive removal techniques will be discussed and evaluated in this review paper. Various MOF-based materials such as functionalized MOFs, MOF-based composites, magnetic MOF-based composites, MOFs templated-metal oxide catalysts for removing pharmaceuticals, personal care products, and antibiotics from contaminated aqueous media are discussed. Furthermore, effective operational parameters on the adsorption, adsorption mechanisms, adsorption isotherms, and thermodynamic parameters are explained and discussed. Finally, in the concluding remarks, the challenges and future outlooks of using MOFs-based adsorbents and catalysts for removing antibiotics are summarized.

Membrane Technological Pathways and Inherent Structure of Bacterial Cellulose Composites for Drug Delivery

This report summarizes efforts undertaken in the area of drug delivery, with a look at further efforts made in the area of bacterial cellulose (BC) biomedical applications in general. There are many current methodologies (past and present) for the creation of BC membrane composites custom-engineered with drug delivery functionality, with brief consideration for very close applications within the broader category of biomedicine. The most emphasis was placed on the crucial aspects that open the door to the possibility of drug delivery or the potential for use as drug carriers. Additionally, consideration has been given to laboratory explorations as well as already established BC-drug delivery systems (DDS) that are either on the market commercially or have been patented in anticipation of future commercialization. The cellulose producing strains, current synthesis and growth pathways, critical aspects and intrinsic morphological features of BC were given maximum consideration, among other crucial aspects of BC DDS.

Extended Release of Metronidazole Drug Using Chitosan/Graphene Oxide Bionanocomposite Beads as the Drug Carrier

This study depicts the facile approach for the synthesis of chitosan/graphene oxide bionanocomposite (Chi/GO) beads via the gelation process. This is the first-ever study in which these Chi/GO beads have been utilized as a drug carrier for the oral drug delivery of metronidazole (MTD) drug, and investigations were made regarding the release pattern of the MTD drug using these Chi/GO beads as a drug carrier for a prolonged period of 84 h. The MTD is loaded on the surface as well as the cavity of the Chi/GO beads to result in MTD-Chi/GO bionanocomposite beads. The MTD drug loading was found to be 683 mg/g. Furthermore, the in vitro release patterns of pure drug and the drug encapsulated with Chi/GO beads are explored in simulated gastric as well as simulated intestinal fluids with phosphate-buffered saline (PBS) of pH 1.2 and 7.4, respectively. As-synthesized bionanocomposite beads have shown excellent stability and capacity for extended release of the MTD drug as compared to the pure drug in terms of bioavailability in both media. The cumulative release data are fitted with the Korsmeyer-Peppas kinetics and first-order reaction kinetics at pH 1.2 and 7.4. The synthesized bionanocomposite beads have good potential to minimize the multiple-dose frequency with the sustained drug release property and can reduce the side effects due to the drug.

Sustainable Synthesis of MOF-5@GO Nanocomposites for Efficient Removal of Rhodamine B from Water

Herein, a metal-organic framework (MOF-5) is synthesized by a solvothermal process and graphene oxide (GO) is prepared from the improved Hummer's method. The synthesis of MOF-5@GO nanocomposites is one-pot process via a grinding method and employed for the removal of Rhodamine B (RhB) dye. The removal efficiency of RhB is found to be 60.64% (151.62 mg·g-1) at 500 ppm. About 98.88% of RhB is removed within 5 min of contact time and increased up to 99.68% up to 10 min. The removal rate of MOF-5@GO nanocomposites is much better than that of pristine MOF-5. Equilibrium adsorption capacity is determined by a series of different experimental conditions such as pH, time, and concentration of dye solution. Although the results also showed that dye removal on MOF-5@GO nanocomposites is well described by the Langmuir isotherm (R 2 = 0.9703), the adsorption kinetics data reveals pseudo-second-order (R 2 = 0.9908). The synthesized nanocomposite is efficient for removal of dye, cost-effective, and reusable. Additionally, stability and self-degradation studies of pure RhB are reported in aqueous solution for up to 120 days at different pH values (pH 1-12).

Synthesis, crystal structure, the Hirshfeld surface analysis, and antimicrobial activity of a three-dimensional Cu(II) complex with N-substituted biguanide

A new antibacterial complex C4H15CuN5O7S, which is derived from the non-insulin-dependent diabetes mellitus drug metformin hydrochloride (MH) and cupric sulfate pentahydrate, is prepared and characterized. The complex shows that a three-dimensional supramolecular structure and the intermolecular interactions are analyzed by the Hirshfeld surface analysis. More importantly, compared with the MH free ligand, the present complex shows excellent antimicrobial activity, especially for Gram-negative bacteria.

Mechanistic Understanding From Molecular Dynamics Simulation in Pharmaceutical Research 1: Drug Delivery

In this review, we outline the growing role that molecular dynamics simulation is able to play as a design tool in drug delivery. We cover both the pharmaceutical and computational backgrounds, in a pedagogical fashion, as this review is designed to be equally accessible to pharmaceutical researchers interested in what this new computational tool is capable of and experts in molecular modeling who wish to pursue pharmaceutical applications as a context for their research. The field has become too broad for us to concisely describe all work that has been carried out; many comprehensive reviews on subtopics of this area are cited. We discuss the insight molecular dynamics modeling has provided in dissolution and solubility, however, the majority of the discussion is focused on nanomedicine: the development of nanoscale drug delivery vehicles. Here we focus on three areas where molecular dynamics modeling has had a particularly strong impact: (1) behavior in the bloodstream and protective polymer corona, (2) Drug loading and controlled release, and (3) Nanoparticle interaction with both model and biological membranes. We conclude with some thoughts on the role that molecular dynamics simulation can grow to play in the development of new drug delivery systems.